Genocea Biosciences, Inc. (NASDAQ:GNCA), a company developing T
cell-directed vaccines and immunotherapies, today announced that it has
entered into a loan and security agreement with Hercules Technology
Growth Capital, Inc. (NYSE:HTGC) for a term loan of up to $27.0 million.
Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™,
today announced that it has entered into a loan and security agreement
with Hercules Technology Growth Capital, Inc. (NYSE:HTGC) for a term
loan of up to $26.0 million and completed a private placement for $1.0
million of Cerulean common stock with Hercules.
Reading International, Inc. (NASDAQ:RDI) announced today the signing of
a new $55.0 million credit facility with Bank of America (“BofA”) and a
postponement in the retirement date of its CFO, Andrzej Matyczynski.
Trevi Therapeutics, Inc. (“Trevi”), a late-stage clinical development
company focused on developing Nalbuphine
ER for chronic pruritus conditions, today announced the closing of a
$15 million senior secured term loan agreement provided by Solar Capital
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.